SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+9.9%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.89B
AUM Growth
+$159M
(+9.2%)
Cap. Flow
+$41.8M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
355
New
45
Increased
117
Reduced
138
Closed
28
Top Buys
| 1 |
Capital One
COF
|
$39.1M |
| 2 |
Envista
NVST
|
$25.6M |
| 3 |
West Pharmaceutical
WST
|
$24M |
| 4 |
JPMorgan Chase
JPM
|
$23.4M |
| 5 |
Eaton
ETN
|
$16.4M |
Top Sells
| 1 |
Allstate
ALL
|
$23.8M |
| 2 |
Apple
AAPL
|
$22.3M |
| 3 |
Cadence Design Systems
CDNS
|
$21.7M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$20.7M |
| 5 |
Zebra Technologies
ZBRA
|
$17.1M |
Sector Composition
| 1 | Technology | 30.41% |
| 2 | Consumer Discretionary | 14.8% |
| 3 | Healthcare | 14.63% |
| 4 | Financials | 11.82% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cisco
CSCO
$264B
| $8K | ﹤0.01% |
146
| – | – |
|
277
Duke Energy
DUK
$93.8B
| $8K | ﹤0.01% |
81
| – | – |
|
278
TechnipFMC
FTI
$16B
| $8K | ﹤0.01% |
1,010
-132
| -12% | -$1.05K |
|
279
Intercontinental Exchange
ICE
$99.8B
| $8K | ﹤0.01% |
75
+7
| +10% | +$747 |
|
280
Marsh & McLennan
MMC
$100B
| $8K | ﹤0.01% |
66
+6
| +10% | +$727 |
|
281
Natera
NTRA
$23.1B
| $8K | ﹤0.01% |
80
-2,090
| -96% | -$209K |
|
282
Ultragenyx Pharmaceutical
RARE
$3.07B
| $8K | ﹤0.01% |
70
-1,890
| -96% | -$216K |
|
283
Southern Company
SO
$101B
| $8K | ﹤0.01% |
128
| – | – |
|
284
Verizon
VZ
$187B
| $8K | ﹤0.01% |
129
| – | – |
|
285
Aon
AON
$79.9B
| $7K | ﹤0.01% |
32
+3
| +10% | +$656 |
|
286
Arrowhead Research
ARWR
$4.02B
| $7K | ﹤0.01% |
110
-3,190
| -97% | -$203K |
|
|
BPMC
287
DELISTED
Blueprint Medicines
BPMC
| $7K | ﹤0.01% |
70
-1,790
| -96% | -$179K |
|
288
B2Gold
BTG
$5.52B
| $7K | ﹤0.01% |
1,550
+210
| +16% | +$948 |
|
289
Fate Therapeutics
FATE
$116M
| $7K | ﹤0.01% |
90
-2,490
| -97% | -$194K |
|
290
General Mills
GIS
$27B
| $7K | ﹤0.01% |
108
| – | – |
|
291
Kimberly-Clark
KMB
$43.1B
| $7K | ﹤0.01% |
47
| – | – |
|
292
Moody's
MCO
$89.5B
| $7K | ﹤0.01% |
25
+3
| +14% | +$840 |
|
293
Sanmina
SANM
$6.44B
| $7K | ﹤0.01% |
160
-4,180
| -96% | -$183K |
|
294
Vale
VALE
$44.4B
| $7K | ﹤0.01% |
380
+50
| +15% | +$921 |
|
295
BridgeBio Pharma
BBIO
$10.2B
| $6K | ﹤0.01% |
100
-2,890
| -97% | -$173K |
|
296
Clorox
CLX
$15.5B
| $6K | ﹤0.01% |
30
| – | – |
|
297
Halozyme
HALO
$8.76B
| $6K | ﹤0.01% |
150
-4,290
| -97% | -$172K |
|
298
HealthStream
HSTM
$834M
| $6K | ﹤0.01% |
270
-7,670
| -97% | -$170K |
|
299
KB Home
KBH
$4.63B
| $6K | ﹤0.01% |
130
-3,790
| -97% | -$175K |
|
300
Magnolia Oil & Gas
MGY
$4.38B
| $6K | ﹤0.01% |
+520
| New | +$6K |
|